TRANSGENIC PIG EXPRESSING STNFR1-FC AND USE THEREOF
摘要
PURPOSE: A transgenic pig and the use thereof are provided to offer pharmaceutical composition of inflammation diseases. CONSTITUTION: A transgenic pig is as follows. The sTNFR1-Fc is expressed from the blood of pig and suppresses the activity of TNF-α. Inflammation is immune rejection reaction occurring in the organ transfer. The pig is produced through the next process. Somatic cells are separated from a pig. The human TNFR1-Fc fusion gene is introduced into the somatic cells. The somatic cells are sorted and are cultivated. The nucleus of the pig ovum is eliminated. A fertilized egg in which the somatic nucleus is transplanted is manufactured by removing the nucleus of the pig ovum and fusing the nucleus with the selected somatic cell. The fertilized egg is implanted.
申请公布号
KR20120085126(A)
申请公布日期
2012.07.31
申请号
KR20110006561
申请日期
2011.01.21
申请人
SNU R&DB FOUNDATION
发明人
AHN, CU RIE;LEE, BYEONG CHUN;HWANG, JONG IK;YANG, JAE SEOK;MOON, BYOUNG GON;JANG, GOO;CHO, BUM RAE;KOO, OK JAE;PARK, SOL JI;KANG, JUNG TAEK;KWON, DAE KEE